DTIL

#3734
Precision BioSciences, Inc. Common Stock
7.16 USD
+0.42%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
7.14
7.22
Year Range
3.53
8.82
Daily Change
+0.42%
Monthly Change
+26.28%
6 month change
+21.15%
Year Change
+36.38%
Previous Close
7.13
Open
7.21
Bid
Ask
Low
7.14
High
7.22
Volume
13
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Precision BioSciences Inc

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

News